Koen Blot

Koen Blot

Auto-generated profile, based on publicly available information

Koen Blot

Department of Epidemiology and Public Health, Sciensano

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2014 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
KBKoen Blot
Koen Blot
JBJochen Bergs
Jochen Bergs
DVDirk Vogelaers
Dirk Vogelaers
SBStijn Blot
Stijn Blot
DVDominique Vandijck
Dominique Vandijck
This systematic review and meta-analysis examines the impact of quality improvement interventions on central line–associated bloodstream infections in adult intensive care units. Studies were identified through Medline and manual searches (1995–June 2012). Random-effects meta-analysis obtained pooled odds ratios (ORs) and 95% confidence intervals (CIs). Meta-regression assessed the impact of bundle/checklist interventions and high baseline rates on intervention effect. Forty-one before–after studies identified an infection rate decrease (OR, 0.39 [95% CI, .33–.46]; P < .001). This effect was more pronounced for trials implementing a bundle or checklist approach (P = .03). Furthermore, meta-analysis of 6 interrupted time series studies revealed an infection rate reduction 3 months postintervention (OR, 0.30 [95% CI, .10–.88]; P = .03). There was no difference in infection rates between studies with low or high baseline rates (P = .18). These results suggest that quality improvement interventions contribute to the prevention of central line–associated bloodstream infections. Implementation of care bundles and checklists appears to yield stronger risk reductions.

1 March 2021 in The Lancet Regional Health - Europe
Verified
Journal Article
Open access
Fabio Silvio TacconeFabio Silvio Taccone
Fabio Silvio Taccone
NGNina Van Goethem
Nina Van Goethem
RPRobby De Pauw
Robby De Pauw
XWXavier Wittebole
Xavier Wittebole
KBKoen Blot
Koen Blot
DBDominique Van Beckhoven
Dominique Van Beckhoven
Several studies have investigated the predictors of in-hospital mortality for COVID-19 patients who need to be admitted to the Intensive Care Unit (ICU). However, no data on the role of organizational issues on patients’ outcome are available in this setting. The aim of this study was therefore to assess the role of surge capacity organisation on the outcome of critically ill COVID-19 patients admitted to ICUs in Belgium. We conducted a retrospective analysis of in-hospital mortality in Belgian ICU COVID-19 patients via the national surveillance database. Non-survivors at hospital discharge were compared to survivors using multivariable mixed effects logistic regression analysis. Specific analyses including only patients with invasive ventilation were performed. To assess surge capacity, data were merged with administrative information on the type of hospital, the baseline number of recognized ICU beds, the number of supplementary beds specifically created for COVID-19 ICU care and the “ICU overflow” (i.e. a time-varying ratio between the number of occupied ICU beds by confirmed and suspected COVID-19 patients divided by the number of recognized ICU beds reserved for COVID-19 patients; ICU overflow present when this ratio is ≥ 1.0). Over a total of 13,612 hospitalised COVID-19 patients with admission and discharge forms registered in the surveillance period (March, 1 to August, 9 2020), 1903 (14.0%) required ICU admission, of whom 1747 had available outcome data. Non-survivors (n=632, 36.1%) were older and had more frequently various comorbid diseases than survivors. In the multivariable analysis, ICU overflow, together with older age, presence of comorbidities, shorter delay between symptom onset and hospital admission, absence of hydroxychloroquine therapy and use of invasive mechanical ventilation and of ECMO, was independently associated with an increased in-hospital mortality. Similar results were found among the subgroup of invasively ventilated patients. In addition, the proportion of supplementary beds specifically created for COVID-19 ICU care to the previously existing total number of ICU beds was associated with increased an in-hospital mortality among invasively ventilated patients. The model also indicated a significant between-hospital difference in in-hospital mortality, not explained by the available patients and hospital characteristics. Surge capacity organisation as reflected by ICU overflow or the creation of COVID-19 specific supplementary ICU beds were found to negatively impact ICU patient outcomes. No funding source was available for this study.

21 April 2022 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
KAKostoula Arvaniti
Kostoula Arvaniti
GDGeorge Dimopoulos
George Dimopoulos
MAMassimo Antonelli
Massimo Antonelli
KBKoen Blot
Koen Blot
BCBen Creagh-Brown
Ben Creagh-Brown
SBStijn Blot
Stijn Blot

12 May 2021 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Open access
PDF file
KBKoen Blot
Koen Blot
NHNaïma Hammami
Naïma Hammami
SBStijn Blot
Stijn Blot
DVDirk Vogelaers
Dirk Vogelaers
MLMarie-Laurence Lambert
Marie-Laurence Lambert
Background: Hospital-acquired bloodstream infections (HABSIs) cause increased morbidity, mortality, and hospital costs that are partially preventable. HABSI seasonality has been described for gram-negative bacteria but has not been stratified per infection origin.Objective: To assess seasonality among all types of HABSIs and their associations with climate.Methods: Hospitals performing surveillance for at least 1 full calendar year between 2000 and 2014 were included. Mixed-effects negative binomial regression analysis calculated the peak-to-low monthly ratio as an adjusted HABSI incidence rate ratio (IRR) with 95% confidence intervals (CIs). Another regression model examined associations between HABSI rates and climate variables. These analyses were stratified by microorganism and infectious origin.Results: The study population included 104 hospitals comprising 44,111 HABSIs. Regression analysis identified an incidence rate ratio (IRR) peak in August for gram-negative HABSIs (IRR, 1.59; 95% CI, 1.49–1.71), CLABSIs (IRR, 1.49; 95% CI, 1.30–1.70), and urinary tract HABSI (IRR, 1.52; 95% CI, 1.34–1.74). The gram-negative incidence increased by 13.1% (95% CI, 9.9%–16.4%) for every 5°C increase in temperature. Seasonality was most present among E. coli, K. pneumoniae, E. cloacae, and the nonfermenters. Gram-positive and pulmonary HABSIs did not demonstrate seasonal variation.Conclusions: Seasonality with summer spikes occurred among gram-negative bacteria, CLABSIs, and urinary tract HABSIs. Higher ambient temperature was associated with gram-negative HABSI rates. The preventable causative factors for seasonality, such as the nurse-to-patient ratio, indoor room temperature or device-utilization, need to be examined to assess areas for improving patient safety.

23 April 2019 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Closed access
PDF file
KBKoen Blot
Koen Blot
NHNaïma Hammami
Naïma Hammami
SBStijn Blot
Stijn Blot
DVDirk Vogelaers
Dirk Vogelaers
MLMarie-Laurence Lambert
Marie-Laurence Lambert
The epidemiology of hospital-acquired bloodstream infections (HABSIs) based on the Belgian national surveillance program was analyzed (2000–2014). Our mixed-effects regression analysis identified increased rates of Escherichia coli, Klebsiella pneumoniae, and Enterococcus faecium. HABSI incidence and resistance patterns should be further monitored because of their impact on proper empiric antibiotic therapy.

29 November 2021 in Transplant Infectious Disease
Verified
Journal Article
Closed access
PDF file
JKJoachim Klein
Joachim Klein
JRJordi Rello
Jordi Rello
GDGeorge Dimopoulos
George Dimopoulos
PBPierre Bulpa
Pierre Bulpa
KBKoen Blot
Koen Blot
SBStijn Blot
Stijn Blot